Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Protara Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Advancing Its Therapies For The Treatment Of Cancer And Rare Diseases. Its Drug Development Pipeline Includes: Tara-002, An Investigational Cell Therapy In Development For The Treatment Of Non-Muscle Invasive Bladder Cancer (Nmibc) And Lymphatic Malformations (Lms); And Iv Choline Chloride, An Investigational Phospholipid Substrate Replacement Therapy, For Patients Receiving Parenteral Support, Or Ps, Which Includes Both Nutrition And Fluids.